Mycophenolate Mofetil in Tanzania: NEMLIT level, who can prescribe it and STG references

Mycophenolate Mofetil is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 8 or more sections.

Last updated

Prescribe on DukadawaRxAsk DukadawaRx AI

New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.

Is mycophenolate Mofetil available on the DukaDawa pharmacy network?

Not yet. Mycophenolate Mofetil is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.

Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.

Is mycophenolate Mofetil on the NEMLIT, and who can prescribe it?

Yes. Mycophenolate Mofetil is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). At level S it may be prescribed by specialists.

Level
S (zonal, special and national hospitals)
Category
Antineoplastics, Immunosuppressives and Immunomodulators
Listed forms
Tablet 500mg
Page
NEMLIT, p. 14
Who may prescribe at each NEMLIT level (STG/NEMLIT 7th edition, Part I, Table 1). Levels listed for this medicine are highlighted.
LevelFacilityWho may prescribe
ADispensarySpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer
BHealth centreSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer
CCouncil or district hospitalSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer
DRegional referral hospitalSpecialist, Medical Officer, Dental Officer
S (listed)Zonal, special and national hospitalsSpecialist

A medicine is listed from the lowest facility level where it should be available.

Where is mycophenolate Mofetil in the Standard Treatment Guidelines?

The Standard Treatment Guidelines (7th edition, 2026) mention mycophenolate Mofetil in 8 or more sections, most often section 21.4.2 Glomerular Diseases (GD) > Nephrotic syndrome (p. 541). See the STG for treatment details.

  • 21.4.2 Glomerular Diseases (GD) > Nephrotic syndrome, p. 541
  • 21.5.3.4 Kidney Transplantation > Transplant Recipient > Maintenance Immunosuppressive Medication, p. 548
  • 3.5 Hematopoietic Stem Cell Transplantation, p. 84
  • 8.8.2 Demyelinating Disorders > Neuromyelitis Optica Spectrum Disorder (NMOSD), p. 190
  • 8.8.3 Demyelinating Disorders > Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease (MOGAD), p. 191
  • 8.10.1 Neuromuscular Junction disorders > Myasthenia Gravis (MG), p. 196
  • 10.5.2 Disorders of The Liver and Biliary Tract > Autoimmune Hepatitis (AIH), p. 253
  • 13.15 Autoimmune Blistering Diseases, p. 330

Sections that mention Mycophenolate Mofetil, most mentions first. Positions only: see the STG for treatment details.

Related medicines

All antineoplastics, immunosuppressives and immunomodulators on the NEMLIT

Sources

  • Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania

Page last updated

STG positions are section numbers and printed page numbers only.

This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.

For licensed prescribers and pharmacists. Not medical advice. Check the Standard Treatment Guidelines before prescribing.